Integrated Filing — IndAS


General information about company

Scrip Code 516072
NSE Symbol VISHNU
MSEI Symbol NOTLISTED
ISIN INE270I01022
Name of company VISHNU CHEMICALS LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 15-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 08-May-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Operating Segment
Start date and time of board meeting 15-May-2025   14:30:00
End date and time of board meeting 15-May-2025   15:50:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion



Financial Results Ind-AS

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Unaudited Audited
D Nature of report standalone or consolidated Consolidated Consolidated
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 3926326000 14465622000
Other income 56946000 153142000
Total income 3983272000 14618764000
2 Expenses
(a) Cost of materials consumed 2017699000 6809716000
(b) Purchases of stock-in-trade 0 0
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade -358498000 -719648000
(d) Employee benefit expense 169621000 648589000
(e) Finance costs 83492000 372967000
(f) Depreciation, depletion and amortisation expense 81315000 381571000
(f) Other Expenses
1 Cost of Consumables 468716000 1858195000
2 Power Cost 245765000 821383000
3 Manufacturing Expenses 309087000 1088334000
4 Selling & Administrative Expenses 426377000 1647495000
5 Other Expenses 6960000 27838000
Total other expenses 1456905000 5443245000
Total expenses 3450534000 12936440000
3 Total profit before exceptional items and tax 532738000 1682324000
4 Exceptional items 0 0
5 Total profit before tax 532738000 1682324000
6 Tax expense
7 Current tax 137955000 338429000
8 Deferred tax 5395000 77468000
9 Total tax expenses 143350000 415897000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0 0
11 Net Profit Loss for the period from continuing operations 389388000 1266427000
12 Profit (loss) from discontinued operations before tax 0 0
13 Tax expense of discontinued operations 0 0
14 Net profit (loss) from discontinued operation after tax 0 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0 0
16 Total profit (loss) for period 389388000 1266427000
17 Other comprehensive income net of taxes 19001000 40609000
18 Total Comprehensive Income for the period 408389000 1307036000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 134631000 134631000
Face value of equity share capital 2 2
27 Details of debt securities
22 Reserves excluding revaluation reserve 9133027000
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 5.82 19.23
Diluted earnings (loss) per share from continuing operations 5.82 19.23
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 5.82 19.23
Diluted earnings (loss) per share from continuing and discontinued operations 5.82 19.23
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Notes n1.The above audited consolidated financial results of Vishnu Chemicals Limited the Holding Company or the Companyits wholly-owned subsidiaries i.e., Vishnu Barium Private Limited,Vishnu Strontium Private Limited and Vishnu South Africa Pty Ltd, VCHEM Global Inc.,Vishnu International Trading FZE and its step-down subsidiary Ramadas Minerals Private Limited and VCHEM Trading FZE together referred to as the Group has been reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on May 15, 2025. The results for the year ended March 31, 2025 has been audited and for the quarter ended March 31,2025 has been reviewed by our statutory auditors. The statutory auditors of the company have expressed an unmodified opinion thereon. n2.These Consolidated financial results of the Company have been prepared in accordance with the Indian Accounting Standards IndAS prescribed under section 133 of the Companies Act, 2013 the Actread with relevant rules issued thereunder and other accounting principles generally accepted in India and guidelines issued by the Securities and Exchange Board of India SEBI. n3.The Board of Directors at their meeting held on May 15, 2025 a recommended a final dividend of Rs0.30 per equity share of face value of Rs 2 each i.e. 15percent, for the financial year 2024 25, subject to approval of the Shareholders of the Company at ensuing Annual General Meeting. n4.The Board of Directors of the Company, at its meeting held on January 24, 2025, allotted 17,88,089 Equity Shares of Rs. 2 each, at an issue price of Rs. 428.60 per share Including premium, pursuant to the conversion of 7,66,37,500 7 percent Compulsory Convertible Preference Shares of Rs. 10 each. Pursuant to the aforesaid allotment of equity shares, the total number of issued, subscribed and paid-up equity shares has been increased from 6,55,27,195 to 6,73,15,284. The Company has received trading and listing approval from both stock exchanges for the aforesaid equity shares. n5.The consolidated financial results include the results of the wholly owned subsidiaries Vishnu Barium Private Limited, Vishnu Strontium Private Limited and Vishnu South Africa Pty Ltd and stepdown wholly owned subsidiaries i.e. Ramadas Minerals Private Limited and VCHEM Trading FZE. VCHEM Global Inc. and Vishnu International Trading FZE have not yet commenced their operations. n6.The figures for the current quarter and quarter ended 31 March 2024 are the balancing figures between the audited figures for the financial year ending 31 March 2025 and March 31, 2024 respectively and the year to date figures upto third quarter ending December 31, 2024 and December 31, 2023 respectively. n7.Previous year's figures have been regrouped reclassified,rearranged wherever necessary to correspond with those of the current year n8.The Company and its subsidiaries are engaged in the manufacture and sale of Specialty Chemicals, which constitutes a single reportable business segment as per Ind AS 108 Operating Segments. However, there are two geographical revenue areas i.e. 1 Domestic 2 Overseas. The breakup of Income is as under: n t t t t t t Rs in Lakhs nSl. nNo.tParticulars Quarter Endedt Year Ended ntt 31-Mar-2025t31-Dec-2024t31-Mar-2024t31-Mar-2025t31-Mar-2024 ntt Unauditedt Unaudited t Unaudited t Audited t Audited n1tDomestict 23,682.48 t 18,123.14 t 15,397.79 t 78,262.75 64,315.84 n2tOverseast 15,427.48 t 18,897.15 t 14,515.44 t 65,877.74 56,612.13 n tTotal Sales 39,109.96 t 37,020.29 t 29,913.23 t 144,140.49 t 120,927.97 n



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Consolidated
Assets
1 Non-current assets
Property, plant and equipment 7003435000
Capital work-in-progress 690774000
Investment property 0
Goodwill 0
Other intangible assets 13429000
Intangible assets under development 0
Biological assets other than bearer plants 0
Investments accounted for using equity method 0
Non-current financial assets
Non-current investments 3123000
Trade receivables, non-current 0
Loans, non-current 0
Other non-current financial assets 0
Total non-current financial assets 3123000
Deferred tax assets (net) 0
Other non-current assets 250508000
Total non-current assets 7961269000
2 Current assets
Inventories 4030616000
Current financial asset
Current investments 0
Trade receivables, current 2940131000
Cash and cash equivalents 28119000
Bank balance other than cash and cash equivalents 789323000
Loans, current 0
Other current financial assets 19282000
Total current financial assets 3776855000
Current tax assets (net) 0
Other current assets 569977000
Total current assets 8377448000
3 Non-current assets classified as held for sale 0
4 Regulatory deferral account debit balances and related deferred tax Assets 0
Total assets 16338717000
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 134631000
Other equity 9133027000
Total equity attributable to owners of parent 9267658000
Non controlling interest 0
Total equity 9267658000
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 1593747000
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0
Total Trade payable 0
Other non-current financial liabilities 0
Total non-current financial liabilities 1593747000
Provisions, non-current 14127000
Deferred tax liabilities (net) 542888000
Deferred government grants, Non-current 0
Other non-current liabilities 0
Total non-current liabilities 2150762000
Current liabilities
Current financial liabilities
Borrowings, current 1829102000
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 13519000
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 2852944000
Total Trade payable 2866463000
Other current financial liabilities 19710000
Total current financial liabilities 4715275000
Other current liabilities 136480000
Provisions, current 989000
Current tax liabilities (Net) 67553000
Deferred government grants, Current 0
Total current liabilities 4920297000
3 Liabilities directly associated with assets in disposal group classified as held for sale 0
4 Regulatory deferral account credit balances and related deferred tax liability 0
Total liabilities 7071059000
Total equity and liabilites 16338717000
Disclosure of notes on assets and liabilities



Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Unaudited Audited
Nature of report standalone or consolidated Consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Unaudited Audited
D Nature of report standalone or consolidated Consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeaseurement gains/(losses) on defined benefit plans 148000 -952000
Total Amount of items that will not be reclassified to profit and loss 148000 -952000
2 Income tax relating to items that will not be reclassified to profit or loss 37000 -240000
3 Amount of items that will be reclassified to profit and loss
1 Exchange differences on translating the financial statements of foreign operations 18890000 41321000
Total Amount of items that will be reclassified to profit and loss 18890000 41321000
4 Income tax relating to items that will be reclassified to profit or loss 0 0
5 Total Other comprehensive income 19001000 40609000



Cash flow statement, indirect

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 2024-04-01
B Date of end of reporting period 2025-03-31
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Consolidated
Part I Blue color marked fields are non-mandatory.
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 1682324000
Adjustments for reconcile profit (loss)
Adjustments for finance costs 366609000
Adjustments for decrease (increase) in inventories -862523000
Adjustments for decrease (increase) in trade receivables, current -641942000
Adjustments for decrease (increase) in trade receivables, non-current 0
Adjustments for decrease (increase) in other current assets 1294000
Adjustments for decrease (increase) in other non-current assets 0
Adjustments for other financial assets, non-current -54126000
Adjustments for other financial assets, current -122266000
Adjustments for other bank balances 0
Adjustments for increase (decrease) in trade payables, current 599121000
Adjustments for increase (decrease) in trade payables, non-current 0
Adjustments for increase (decrease) in other current liabilities 1432000
Adjustments for increase (decrease) in other non-current liabilities 2457000
Adjustments for depreciation and amortisation expense 381571000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for provisions, current 4763000
Adjustments for provisions, non-current 383000
Adjustments for other financial liabilities, current -952000
Adjustments for other financial liabilities, non-current 0
Adjustments for unrealised foreign exchange losses gains 41321000
Adjustments for dividend income 0
Adjustments for interest income 83755000
Adjustments for share-based payments 0
Adjustments for fair value losses (gains) -156000
Adjustments for undistributed profits of associates 0
Other adjustments for which cash effects are investing or financing cash flow 0
Other adjustments to reconcile profit (loss) -1417000
Other adjustments for non-cash items 0
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments for reconcile profit (loss) -368186000
Net cash flows from (used in) operations 1314138000
Dividends received 0
Interest paid 0
Interest received 0
Income taxes paid (refund) 411861000
Other inflows (outflows) of cash 0
Net cash flows from (used in) operating activities 902277000
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 0
Other cash payments to acquire equity or debt instruments of other entities 0
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property, plant and equipment 0
Purchase of property, plant and equipment 878510000
Proceeds from sales of investment property 13511000
Purchase of investment property 0
Proceeds from sales of intangible assets 0
Purchase of intangible assets 0
Proceeds from sales of intangible assets under development 0
Purchase of intangible assets under development 0
Proceeds from sales of goodwill 0
Purchase of goodwill 0
Proceeds from biological assets other than bearer plants 0
Purchase of biological assets other than bearer plants 0
Proceeds from government grants 0
Proceeds from sales of other long-term assets 0
Purchase of other long-term assets 0
Cash advances and loans made to other parties 0
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 0
Interest received 77372000
Income taxes paid (refund) 0
Other inflows (outflows) of cash -207949000
Net cash flows from (used in) investing activities -995576000
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0
Payments from changes in ownership interests in subsidiaries 0
Proceeds from issuing shares 0
Proceeds from issuing other equity instruments 0
Payments to acquire or redeem entity's shares 0
Payments of other equity instruments 0
Proceeds from exercise of stock options 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings 481863000
Repayments of borrowings 0
Payments of lease liabilities 0
Dividends paid 19629000
Interest paid 364422000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) financing activities 97812000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 4513000
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0
Net increase (decrease) in cash and cash equivalents 4513000
Cash and cash equivalents cash flow statement at beginning of period 23606000
Cash and cash equivalents cash flow statement at end of period 28119000







Details of Impact of Audit Qualification

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 M/s. Jampani & Associates Yes 31-Jan-2028


Financial details

Sr. Particulars Audited Figures (as reported before adjusting for qualifications) Adjusted Figures (audited figures after adjusting for qualifications)
1 Turnover / Total income
2 Total Expenditure
3 Net Profit/(Loss)
4 Earnings Per Share
5 Total Assets
6 Total Liabilities
7 Net Worth




Signatories detail

Name of CEO / Managing director
Name of CFO
Name of audit committee chairman
Name of statutory auditor
Name of other signatory, if any, with designation
Place
Date